Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Psychology Dissertations

Student Dissertations, Theses and Papers

2021

Assessing Factors That Increase the Likelihood of Naloxone
Administration
Samantha Nagy
Philadelphia College of Osteopathic Medicine

Follow this and additional works at: https://digitalcommons.pcom.edu/psychology_dissertations
Part of the Clinical Psychology Commons

Recommended Citation
Nagy, Samantha, "Assessing Factors That Increase the Likelihood of Naloxone Administration" (2021).
PCOM Psychology Dissertations. 545.
https://digitalcommons.pcom.edu/psychology_dissertations/545

This Thesis is brought to you for free and open access by the Student Dissertations, Theses and Papers at
DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Psychology Dissertations by an authorized
administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu.

Philadelphia College of Osteopathic Medicine
School of Professional and Applied Psychology
Department of Clinical Psychology

ASSESSING FACTORS THAT INCREASE THE LIKELIHOOD
OF NALOXONE ADMINISTRATION.

By Samantha Nagy
Submitted in Partial Fulfillment of the Requirements for the Degree of
Doctor of Psychology
June 2020

DISSERTATION APPROVAL
This is to certify that the thesis presented to us by Samantha Nagy on the 28th day of
May 2020 in partial fulfillment of the requirements for the degree of Doctor of
Psychology, has been examined and is acceptable in both scholarship and literary quality.
, David Festinger, PhD. Chairperson
Robert DiTomasso, PhD, ABPP
Michael Dolan, PsyD.
Stephanie Felgoise, PhD, ABPP_____,
Robert DiTomasso, PhD, ABPP

Chair, Department of Clinical Psychology

, Dean, School of Professional & Applied Psychology

iii
ACKNOWLEDGEMENTS
I would like to thank my dissertation chair, Dr. David Festinger, for his help with
my dissertation and growth as a psychologist. Additionally, I am grateful for the other
members of my committee, Drs. Robert DiTomasso and Michael Dolan, for their support
and guidance through the dissertation process. My committee consists of professionals
that I admire for their values, ethics, and knowledge in the field.
I would like to thank my family for their unwavering support and inspiration. My
parents, Scott and Lisa, and my sister, Marissa, have been with me through every step of
this journey. Matt, Ashley, and Grayson, thank you for taking me in and ensuring that I
never stop taking care of myself or give up on my dreams. Jess, thank you for always
supporting me through everything regardless of the changes in our social life because of
my schooling. Abbey, thank you for being my longest friend and always keeping me
grounded. Paige and Lindsay, thank you for continuously encouraging me to keep
working toward my goal of being a psychologist.
Thank you, Zach, for being a constant and continuous source of support and
motivation. Your countless pep talks gave me the final push to never give up and to do
the best I can to achieve my goals to best help future patients.
Finally, thank you to Sam Lyon, Kaylene Irizarry, Matt Bloom, Laura Salciunas,
and the rest of my cohort. This journey was one that we could not have done alone and I
am grateful to have experienced it with each one of you. Team work makes the dream
work!

iv
TABLE OF CONTENTS
ABSTRACT........................................................................................................................ 1
CHAPTER 1: INTRODUCTION ....................................................................................... 2
Statement of the Problem .................................................................................................... 2
Purpose of the Study ........................................................................................................... 2
Research Questions and Hypotheses .................................................................................. 3
CHAPTER 2: REVIEW OF THE LITERATURE ............................................................. 6
Scope of the Opioid Epidemic ............................................................................................ 7
Treatment Approaches ...................................................................................................... 10
Overdose Reversal ............................................................................................................ 13
Possible Barriers to Naloxone Administration ................................................................. 15
CHAPTER 3: METHOD .................................................................................................. 18
Participants ........................................................................................................................ 18
Measures ........................................................................................................................... 18
Procedure .......................................................................................................................... 22
CHAPTER 4: RESULTS .................................................................................................. 24
Sample Demographics ...................................................................................................... 22
Bivariate Correlations ....................................................................................................... 22
Logistic Regression........................................................................................................... 22
CHAPTER 5: DISCUSSION............................................................................................ 31
Interpretation and Implications ......................................................................................... 31
Limitations ........................................................................................................................ 34
Future Directions .............................................................................................................. 37

v
REFERENCES ..................................................................Error! Bookmark not defined.
APPENDIX A: Demographic Questionnaire.................................................................... 46
APPENDIX B: Vignette ................................................................................................... 46
APPENDIX C: Concern Over Legal/Civil Ramifications ................................................ 46
APPENDIX D: Toronto Emapthy Questionnaire ............................................................. 46
APPENDIX E: Affect Scale for Substance Users (AS-SU) ............................................. 50
APPENDIX F: Attributions of Addiction Scale ............................................................... 51

vi
LIST OF TABLES
Table 1. Sample Demographics ........................................................................................ 27
Table 2. Bivariate Correlation Matrix of Predictors and Criterion Variable: Decision to
Administer Naloxone ........................................................................................................ 29
Table 3. Logistic Regression Predicting Decision to Administer Naloxone .................... 30

FACTORS THAT PREDICT NALOXONE ADMINISTRATION

1

ABSTRACT
For more than two decades, the opioid epidemic has swept through the United States and
has caused thousands of deaths every year due to opioid overdose. The Centers for
Disease Control and Prevention (CDC; 2019) has reported that since 1999, over 770,000
Americans have died from overdoses. Nearly 70% of deaths in 2018 were due to opioids,
47% of which were the result of fentanyl or a non-methadone opioid and 22% were the
result of heroin (CDC, 2019). As policy and treatment protocols attempt to manage those
who seek treatment, the pharmaceutical industry has developed a life-saving medication
that gives those who overdose another chance at recovery. Despite legislation allowing
standing prescriptions and statewide access to naloxone, there continues to be some
disconnect toward getting the layperson to be willing to intervene. The present study
computed bivariate correlations and logistic regressions to identify factors that predict a
person’s likelihood of administering naloxone should he or she encounter a person who
has overdosed. An online survey was completed by 129 college students of various
demographics. Factors examined included concern of legal and civil ramification,
empathy, stigma toward substance use, and personal attribution of addiction. Results
indicated the strongest predictor to be empathy. These findings can be used to inform
future research to further foster support for naloxone distribution and use.
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CHAPTER 1: INTRODUCTION
Statement of the Problem
The opioid epidemic is a national health concern that plagues many Americans.
The National Institute on Drug Abuse (NIDA; 2019) has estimated that 72,000
Americans died in 2017 from opioid overdoses. As the number of deaths due to overdose
increases, policymakers and public health officials continue to find ways to mitigate this
problem. In September 2016, the United States Attorney General issued a memorandum
identifying a three-pillar strategy to combat the opioid epidemic. The primary pillar was
prevention, which included prevention of overdose deaths through the utilization of
naloxone. In recent years, there have been a variety of strategic efforts launched to help
combat the opioid epidemic. As the efforts have increased to get naloxone into the hands
of the public, it is important to identify factors that increase its utilization when one
encounters someone who has overdosed.
Purpose of the Study
This study aimed to identify individual characteristics of a person that impact his
or her likelihood of administering naloxone. The study accomplished this by presenting
participants with a vignette in which they were presented an opportunity to administer
naloxone and examining their decided courses of action, degree of empathy, stigma
toward addiction, concern of legal/civil ramifications, and personal attributions of
addiction.
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The results of this study aimed to provide insight into the characteristics that may
increase or reduce the likelihood of someone administering naloxone in the event of an
opioid overdose. The study intended to provide useful information to guide future
research and policy regarding more targeted and impactful naloxone training and
distribution. The purpose of this study was to identify factors that may make people
resistant to administering naloxone in the event they encounter someone who is
experiencing an opioid overdose.
Research Questions and Hypotheses
Hypothesis 1. Participants with higher level of empathy were hypothesized to be
significantly more likely to administer naloxone.
Hypothesis 1 rationale. Leading research notes empathy as an “other-person
oriented emotion that evokes altruistic motivation to reduce other’s needs” (Batson,
Duncan, Ackerman, Buckley, & Birch, 1981). Both empathy and feelings of personal
distress have been found to impact an individual’s decision to perform helping behaviors
(Batson et al., 1981). When feelings of personal distress outweigh empathy, helping
behaviors are decreased (Carrera et al., 2012). It was hypothesized that when a person is
trained in the proper administration of naloxone, his or her empathy would outweigh
feelings of personal distress and facilitate the decision to perform helping behaviors by
administering the naloxone.
Hypothesis 2. Participants with lower levels of stigma toward opioid users were
hypothesized to be significantly more likely to administer naloxone.
Hypothesis 2 rationale. Research has suggested that fear of encountering social
stigma is correlated with a decreased likelihood of calling 911 in the event of
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encountering an overdose, despite Good Samaritan Laws in place (Latimore & Bergstein,
2017). Examining whether this factor extends to the decision to administer naloxone was
intended to provide insight into how the decision to intervene is made.
Hypothesis 3. Participants with a lower level of concern regarding legal/civil
ramifications were hypothesized to be significantly more likely to administer naloxone.
Hypothesis 3 rationale. Research indicates that despite establishment and
education around Good Samaritan Laws, people are still hesitant to involve law
enforcement if they encounter individuals who have overdosed (Koester, Mueller,
Raville, Langegger, & Binswanger, 2017). It is important to establish the degree that
legal or civil concerns may impede naloxone administration for future research to
examine how the public can come to accept and trust the immunity granted by Good
Samaritan Laws.
Hypothesis 4. Participants with a significantly lower degree of negative
attribution toward those who use opioids were hypothesized to be more likely to
administer naloxone.
Hypothesis 4 rationale. Research demonstrates a continued lack of
understanding regarding the conceptualization of addiction as a disease, as well as
support of the idea that habitual drug use is the result of free will (Vonasch, Clark, Lau,
Vohs, & Baumeister, 2017). Research is unclear about whether those who believe drug
use is due to a moral failing and a result of free would support overdose reversal efforts.
Research can definitively state that majority of Americans in today’s society support
some efforts toward combating the opioid epidemic (Barry et al., 2016). It was
hypothesized that those who have a low degree of negative attribution, or belief that the
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individual’s drug use is outside the scope of free will, would choose to administer
naloxone. This hypothesis was formulated on the assumption that those who have a
negative attribution toward those using drugs do so because they believe those with
substance use disorders are using solely because of their own poor decisions.
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CHAPTER 2: REVIEW OF THE LITERATURE
People have found ways to use substances to alter their stages of consciousness
since the beginning of time. Psychoactive drug use can be traced back to the prehistoric
period of 8500-4000 B.C. when humans utilized plants and fruits for their psychoactive
properties (Inaba & Cohen, 2007). The most popular mind- and mood-altering
substances have stayed consistent for centuries, including tobacco leaves, the cannabis
plant, team leaves, coca leaves, fruits that ferment into alcohol, and opium poppies
(Austin, 1979).
There has been evidence of opium use in ancient Greece, Spain, Egypt, and
Mesopotamia (Escohotado, 1999). Early Mesopotamians used opium for its medicinal
and psychological properties. It is believed that the plant was used for pain relief, cough
suppression, euphoria, and sedation (Hoffman, 1990). Historical evidence for substance
use demonstrates the human tendency to use mind-altering materials to achieve physical
or psychological effects. The propensity to alter the state of mind lays the foundation for
the substance use seen in current society, specifically the opioid epidemic. Smoking
opium is a practice that dates to the year 1500, when Portuguese traders introduced the
practice to the Chinese people (Inaba & Cohen, 2007). Many years later, Chinese
immigrants brought smoking opium to the United States, introducing opium dens to the
west coast (Kuhn, Swartzwelder, & Wilson, 2003).
Opioids are a class of drug that includes both natural (opiates) and synthetic
(opioid) substances that act on the brain’s opioid receptors. The term opioid is used to
encompass natural, synthetic, and semi-synthetic forms of the substance. The opioid
class of drugs includes common “street” drugs, such as heroin, in addition to medications
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such as morphine, fentanyl, hydrocodone, and oxycodone. The effects of opioids include
pain relief, analgesic properties, sedation, euphoria, reduced heart rate, and depressed
breathing. There have been four opioid receptors identified in the human brain: MOP (µ
= mu), KOP (κ = kappa), DOP (δ = delta), and NOP-R (Waldhoer, Bartlett, & Whistler,
2004). These receptors are naturally occurring and well distributed throughout the body
to accommodate the body’s endogenous pain-relieving processes. When an opioid is
introduced into the body by way of any route of administration that allows it to cross the
blood-brain barrier, it binds to one of the four receptors and produces the effects. An
opioid overdose occurs when an abundance of the substance is introduced into the body
producing toxic effects. NIDA and the CDC concentrate the discussion of the opioid
epidemic to prescription opioid use, heroin, and the recent development of fentanyl use.
Scope of the Opioid Epidemic
The National Survey on Drug Use and Health estimated that in 2017, 3.1% of
individuals between the ages of 12 and 17, 7.2 % of those ages 18 to 25, and 3.7% of
individuals 26 or older were prescribed opioids for pain relief (Center for Behavioral
Health Statistics and Quality, 2017). NIDA (2019) has identified that prescription
opioids have a high potential for abuse and modes of misuse include taking the
medication at a different dosage or route of administration than prescribed, taking opioids
prescribed to another person, or taking the medication for the purpose of an obtaining
altered mind or mood. Commonly prescribed opioids for severe pain include
hydrocodone (Vicodin), oxycodone (OxyContin, Percocet), oxymorphone (Opana),
morphine, codeine, and fentanyl. In 2010, the CDC reported that 81.2 per 100 Americans
were given prescription opioids for pain. Despite efforts to combat the epidemic, in 2017
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there were 58 opioid prescriptions written for every 100 Americans and more than 17%
of Americans had at least one opioid prescription filled (CDC, 2018). Despite the
decrease in percentage of opioid prescriptions written from 2010 to 2017, 58 per 100
Americans equates to 191 million opioid prescriptions in one year alone. It has been
found that as many as 80% of Americans who reported using heroin identified that their
use began with prescription opioids (Muhuri, Gfroerer, & Davies, 2013).
Approximately 2.2% of adults over the age of 26 reported use of heroin within
their lifetimes according to the 2018 National Survey on Drug Use and Health. The same
survey reported 1.8% of those in the 18 to 25 age bracket had used heroin. The
prevalence of heroin use among Americans has been growing since 2007 (Center for
Behavioral Health Statistics and Quality, 2017). Heroin can be used via many routes of
administration, including snorted, injected, or smoked. As previously identified, heroin is
commonly, but not always, the result of progressive substance use (Muhuri et al., 2013).
Illicit fentanyl use continues to gain attention in the discussion of the opioid
epidemic. Fentanyl is a synthetic opioid 50 to 100 times more potent than morphine and
is typically used to manage pain for patients after surgery (NIDA, 2016). In recent years,
the number of overdose deaths attributed to synthetic opioids, identified by the CDC as
being predominantly fentanyl, has grown exponentially. Provisional data for the year
2017 report 29,406 deaths attributable to this classification of opioids. This is a 10,000
increase from the 19,413 reported in 2016, and a 20,000 increase from the approximately
10,000 deaths reported in 2015 (CDC, 2018). Fentanyl can be particularly dangerous due
to its high potency and ability to be mixed into other substances without the user’s
knowledge.
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Opioid-dependent patients are more likely to have HIV, hepatitis C, lower back
pain, posttraumatic stress disorder, psychotic symptoms, and diagnoses of alcohol,
cocaine, or amphetamine use disorders (Barnett, 2009). An increase in likelihood of
other medical conditions results in increased health care costs for this population of
Americans. It has been established that high-risk prescription opioid users have higher
health care costs and utilization records than non-users (Chang, Kharrazi, Bodycombe,
Weiner, & Alexander, 2018). A “value of statistical life” analytic method estimated the
true cost to society is $504 billion dollars, including work-productivity, earnings, and
raising families (Ryan, 2018). According to a 2016 analysis of the 2013 calendar year,
the economic burden of the opioid epidemic is $78.5 billion (Florence, Zhou, Luo & Xu,
2016). Florence and colleagues (2016) identified over $28 billion of this sum was
accounted for by health care and substance abuse treatment and $7.7 billion was
attributable to criminal justice-related costs. It can be assumed that these numbers will
continue to grow with the growing number of opioid users.
In 2013, the Office of National Drug Control Policy (ONDCP) released a joint
statement with the Substance Abuse and Mental Health Services Association (SAMHSA)
regarding an “Opioid Toolkit,” which promoted the use of naloxone outside of medical
settings (ONDCP & SAMHSA, 2013). These agencies advocated for law enforcement
officers and laypersons to possess and carry naloxone to assist in the event of overdoses.
Despite the recommendation for law enforcement officers to be trained and equipped
with naloxone, some reports have demonstrated the rate of implementation remains low
(Dudzik, 2017). The Surgeon General has extended the recommendation to include
opioid users’ loved ones to have naloxone in their homes (U.S. Surgeon General, 2018).
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Treatment Approaches
The need for substance use treatment has been present since humans began using
mind- and mood-altering substances. Just as ancient records indicate that people used
various substances for mind-altering experiences, records also indicate the historical need
for treatment. Ancient Egyptians recorded those with alcoholism being sanctioned to
private homes, and the Ancient Romans and Greeks recorded treating substance use with
asylums (White, 1998). Since ancient times, treatment has continued to evolve. The
evolution of treatment can be broken down into treatment based on the moral model, the
12-Step approach, and medication-assisted treatment.
Moral model. The initial stages of treatment in America can be traced back to the
practices of incarceration. Those labeled “drunkards” were typically placed in jail for
their behaviors (Rosenberg, 1995). Societal practices of incarceration as a result of
misusing alcohol was somewhat counterintuitive given records of alcohol being provided
to inmates in prisons (Rothman, 2001). This practice demonstrated the lack of
knowledge regarding a logical explanation for the behaviors of those misusing
substances. The passing of the Harrison Narcotics Tax Act in 1914 reinforced this belief
by heavily regulating opium and coca products (Inaba & Cohen, 2007). Prior to the
passing of this law, opium and coca products were widely used to treat morphine and
alcohol addiction (Henniger & Sung, 2014). Regulating these practices contributed to the
moral model by implying that addiction should be criminalized due to the illegalization
of the substances used to treat addiction-related behaviors. The American Association
for the Cure of Inebriation was the first organization to attempt to transition the treatment
of addiction to a professional service when proponents advocated that addiction should be
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treated as a disease rather than a criminal act that should be punished (Henniger & Sung,
2014).
Mutual assistance programs. Although mutual assistance programs, such as
Alcoholics Anonymous (AA), Narcotics Anonymous, and other 12-step programs, are
not widely considered to be evidenced-based interventions, they are often used as
ancillary services within other treatment programs. These 12-step programs were not the
first self-help groups in America, but they have a strong presence in the development of
recovery from substance use. AA began after prohibition led to the disappearance of
many formal modalities of treatment (White, 1998). The Big Book of Alcoholics
Anonymous states, “half measures have availed us nothing,” encouraging those looking
for sobriety to follow the 12 steps to make a complete lifestyle change incorporating
spiritual principles (AA, 2014). The 12 steps encourage newcomers to adhere to the
guidance of sponsors, those who have had success with the steps in their own recovery
journeys, to make the lifestyle changes necessary to combat the disease of addiction and
abstain from drug use. The Big Book refers to alcohol and other drug addictions as an
allergy, noting those who are addicted cannot tolerate the effects without developing a
dependence, like the “non-addict” (AA, 2014).
Medication-assisted treatment. Medication-assisted treatment (MAT) is used to
define any modality of treatment that combines pharmaceutical intervention within a
holistic treatment plan developed for a patient’s substance dependence (SAMHSA,
2020). SAMHSA (2020) has advised that FDA-approved medications should be initiated
and monitored by trained physicians in combination with other evidenced-based practices
for substance use.
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The historical roots of MAT in the United States can be traced to the 1800s when
cocaine was utilized to treat alcoholism and morphine addiction (White, 1998). In China,
morphine (an opiate) was used to treat opium addiction, and in Europe, heroin was
developed to treat morphine addiction (Inaba & Cohen, 2007). Despite the development
of this treatment approach, MAT is not currently used as a replacement for the original
substance but, rather, to adequately manage both acute and protracted withdrawal
symptoms and cravings to allow the individual to fully participate in the necessary
therapy (SAMHSA, 2020).
Currently, there are three FDA approved medications that are used for the
treatment of opioid use disorder (OUD). These include methadone, a synthetic opioid
receptor agonist, buprenorphine-naloxone (sold under the brand names Suboxone and
Subutex) which acts as a partial agonist, and naltrexone (sold under the brand name
Vivitrol) which acts as a full opioid antagonist. Naltrexone can be given via a daily oral
pill or a once monthly intramuscular injection (NIDA, 2019). The availability of MAT
has been found to decrease illicit opioid use, criminal activity, and the transmission of
infectious disease (Mattick, 2014; Mattick, Breen, Kimber, & Davoli., 2009; Schwartz et.
al., 2013).
Research has shown that MAT is most effective when combined with
psychosocial intervention. It has been demonstrated that methadone maintenance and
cognitive behavioral therapy are effective; however, little research has been done on
other types of MAT and modalities of therapy (Dugosh et al., 2016).
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Overdose Reversal
Despite many interventions and treatment modalities that have been used with
varying degrees of success, most recent research indicates that more than 72,000
overdose deaths due to opioid use occurred in 2017 (NIDA, 2019). Naloxone (sold
commonly under the brand name Narcan) was developed to reverse an occurrence of an
opioid overdose and can be used to save a life during an emergent situation.
Naloxone is an opioid antagonist that binds to the brain’s opioid receptors and
reverses the physical effects of an overdose. When the physical effects of an overdose
are reversed, the person immediately experiences symptoms of opioid withdrawal. This
reversal will restore normal breathing and other bodily functions and can be used with all
drugs within the opioid class (NIDA, 2019). If naloxone is given to an individual who
does not have opioids in his or her system, there will be no effect. Naloxone is a shortacting medication that wears off in 20 to 90 minutes (harmreduction.org, 2020). Because
of the short-acting nature, it is important to get the individual to an emergency
department after being given any amount of naloxone because he or she may need
additional doses after the initial dose wears off (NIDA, 2019).
NIDA (2019) identified three possible administrations of naloxone: injectable,
auto-injectable, and nasal spray. The Food and Drug Administration (FDA) requires the
injectable form to be administered by trained medical professionals, whereas it
recommends the auto-injectable and nasal spray for laypeople with appropriate training
(FDA, 2016).
Naloxone is becoming more widely distributed among first responders and the
public. Permissions for the overdose reversal are dependent on state laws; however,
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states are passing legislation to provide the drug to the public. Legislation is supported
by the recommendation by the ONDCP for any member of the public to be trained and
obtain naloxone if a loved one or family member is at risk for an opioid overdose
(ONDCP & SAMHSA, 2013). Standing orders are being established in most states in the
U.S. to make naloxone more available to the public. A standing order is legislation that
allows a licensed physician to designate a trained layperson as outlined above to obtain
naloxone (University of Maryland, 2016). This allows the public to access naloxone
without facetime with the physician. A statewide standing order, such as the model used
in Pennsylvania, allows the public to access naloxone “from a pharmacy in the event they
are unable to obtain naloxone or a prescription for naloxone from their regular health care
provider” (Pennsylvania Department of Health, 2018). Forty-two states and the District
of Columbia have statewide standing orders (Kokosky, 2018). According to SAMHSA,
every state in the U.S., excluding Nebraska, have models of non-patient-specific
practices, such as standing orders or third-party prescribing privileges (SAHMSA, 2018).
Recent research has demonstrated that education regarding the use and
availability of naloxone within treatment settings is helpful in its distribution to substance
users. Psychoeducation regarding the distribution and use of naloxone increases
knowledge of proper procedure in the event of an opioid overdose (Lott & Rhodes,
2006). Some individuals identified naloxone to be “just as important as a clean needle”
to their using rituals and some individuals demonstrated very low knowledge of the
availability of the lifesaving drug (Heavey et al., 2018). Resistance toward carrying
naloxone by individuals using opioids varies from the size of the kit to reporting no
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longer being around other people who are using drugs (Khatiwoda, R. Proeschold-Bell,
Meade, Park, & S. Proeschold-Bell, 2018).
Possible Barriers to Naloxone Administration
Although it continues to be distributed more broadly and more individuals are
being trained on administration, many individuals continue to experience resistance to
obtaining and utilizing naloxone if encountering overdoses. In addition to bystander
hesitancy, medical professionals have their own hesitancy toward prescribing naloxone to
substance using individuals. Hesitancies have been found to include concerns of lack of
knowledge, third-party education, fear of enabling drug use, and stigma against those
who use opioids (Gatewood, Van Wert, Andrada, & Surkan, 2016). It is important to
consider providers’ apprehensions toward prescribing naloxone as these practices are
likely to trickle down to public consumers.
Knowledge and attitudes. Despite better training and distribution efforts, many
people are unaware of naloxone and have yet to be trained. A lack of knowledge can
make efforts to combat the epidemic futile by allowing stigma and misperceptions to
continue. People continue to view addiction as a loss of free will (Vonasch et al., 2017).
This view can undermine the recovery efforts of those using drugs, as well as the efforts
of those in the field of treating addicted individuals.
Just as the presence of stigma and lack of knowledge can deter efforts to combat
the epidemic, support of the cause can increase efforts. A majority of Americans
recognize the severity of the opioid epidemic and support the efforts to address this
national problem (Barry et al., 2016). It is imperative this support is harnessed with
appropriate knowledge to include the general population in the efforts to spread recovery.
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Having the support of the general population is essential to progressing to the
involvement of the public in efforts to combat the epidemic.
Concern of legal ramifications. As evidence demonstrates a lack of
understanding of substance use, it is possible there is a lack of knowledge surrounding
the legal ramifications of administering naloxone. If a lack of knowledge is present, it is
possible an individual may have a fear of legal implication if he or she becomes involved
in a situation relating to an opioid overdose. It is possible this fear begins with hesitation
by physicians in prescribing naloxone. Research continues to demonstrate physician
apprehension for fear of legal ramifications despite minimal risk (Burris, Norland, &
Edlin, 2001; Davis, Carr, Southwell, & Beletsky, 2015). If the people are concerned
about legal action in response to administering naloxone, they may continue to be
hesitant to utilize the drug despite training and availability. For instance, an individual
may be concerned about his or her own legal implications due to the presence of
paraphernalia on the scene of an overdose.
Many states have established Good Samaritan Laws to assist with this fear. The
National Conference of State Legislatures (2017) reported that 40 states and Washington
D.C. have some form of a Good Samaritan Law that protects those who call emergency
medical professionals for overdoses. Research has shown that fear of repercussions
persists despite the presence and knowledge of Good Samaritan Laws in the instances of
drug overdoses (Koester et al., 2017).
Empathy and stigma. In the presence of available naloxone, appropriate
training, and adequate knowledge regarding drug use and applicable legislation, a person
encountering an individual who has overdosed needs to make a decision about whether to
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intervene. It is possible this decision is made based on the person’s level of empathy.
The presence of stigma toward drug using individuals may cause a lack of empathy
toward this population and may deter an individual from intervening.
A lack of empathy and feelings of futility have been demonstrated in first
responder populations when intervening in recurrent cases of drug overdoses (Green et
al., 2013). It is possible this phenomenon permeates the public as well. If an individual
experiences a lack of empathy and feelings of futility toward efforts to combat the opioid
epidemic, he or she may not have motivation to get training or to carry naloxone,
ultimately preventing him or her from intervening in an instance of overdose.
Research demonstrates that increased empathy toward a member of a stigmatized
group ultimately increases the empathy toward the group (Batson, Polycarpou, et al.,
1997). If it is identified that empathy is a contributing factor to a person’s decision to
administer naloxone, it would be imperative to help decrease stigma and raise the levels
of empathy for this population.
Given this data, the present study aimed to identify factors that impact an
individual’s decision to administer naloxone upon encountering a person who is
experiencing an opioid overdose.
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CHAPTER 3: METHOD
The purpose of this study was to identify factors that may make people resistant to
administering naloxone in the event they encounter someone who has overdosed.
Participants were asked to complete a demographic questionnaire, analyze a vignette, and
complete three measures. A within-group, correlational design was used in this study.
The results of this study were interpreted using a logistic regression.
Participants
The participants in this study were students in undergraduate universities and
trade/technical schools (N = 130). Participants were recruited for this study through a
sample of convenience using an online student listserv. The students were not
compensated for their participation; however, all participants were entered in a drawing
to win one of four $25.00 Amazon gift cards.
Inclusion and exclusion criteria. Individuals were permitted to participate in
this study if they were 18 years of age and older, students in undergraduate or
technical/trade schools, had access to computers, and were willing to participate in the
survey. Individuals were excluded from this study if they were under 18 years of age,
had a non-student status, and were unwilling to participate in the study. Naloxone
training was used as a hypothetical in the vignette; therefore, training was not a
requirement to participate in the study.
Measures
Six instruments were used in this online inquiry: (a) demographic and personal
history questionnaire, (b) vignette, (c) Toronto Empathy Questionnaire, (d) Affect Scale
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for Substance Users, (e) Likert-type scale regarding concern of legal/civil ramifications,
and (f) Modified Attributions of Obesity Scale (AOAS).
Demographic and personal history questionnaire. Participants were given a
demographic questionnaire developed by the researcher. Demographic information
collected by this questionnaire included gender, age, ethnicity, socioeconomic status,
exposure to substance use disorders, and whether the participant has had a loved one
revived with naloxone.
Vignette. Participants were asked to read a vignette detailing an experience in
which they encountered someone who was demonstrating symptoms of an opioid
overdose. The vignette informed the participant that he or she has been trained in the use
of naloxone and has it available to him or her at the time he or she encounters the
individual who has overdosed. After the vignette, the participant was asked to indicate
his or her next actions in the scenario. Potential answers included “administer naloxone,”
“ask someone else to administer the naloxone,” “call 911,” “ensure a witness calls 911,”
or “not get involved.” After indicating his or her next course of action, the participant
was asked to rate his or her confidence that this choice would match his or her actions
should this situation be encountered outside of an imaginal circumstance.
Toronto Empathy Questionnaire. The third measure used in this study was the
Toronto Empathy Questionnaire (TEQ; Spreng, McKinnon, Mar, & Levine, 2009). This
is a self-report measure that measures attributes associated with empathy. Items 1 and 4
measure the perception an individual has of the emotional state of another person. Item 8
assesses emotion comprehension in others. Items 2, 7, 10, 12 ,and 15 measure emotional
states in others by indexing the frequency of behaviors. Items 3, 6, 9, and 11 gauge
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physiological arousal. Items 5, 14, and 16 measure altruism. Item 13 is indicative of
higher-order empathy, such as prosocial behavior (Spreng et al., 2009).
The TEQ is a series of 16 statements in which participants are asked to rate how
frequently they feel or act as the statement describes. The TEQ is scored using the
following rating: Never = 0, Rarely = 1, Sometimes = 2, Often = 3, Always = 4. The
higher the score, the more empathy the participant demonstrates (Spreng et al., 2009).
The TEQ correlated positively with the Empathy Quotient, r = .80, p < .01 and
negatively with the Autism Quotient, r = -.33, p <.01 (Spreng et al., 2009). The TEQ
demonstrated internal consistency of α =.87 and high test-retest reliability, r =.81, p <
.001 (Spreng et al., 2009).
Affect Scale for Substance Users. The Affect Scale for Substance Users (ASSU) is a scale designed to measure the amount of stigma the participant has toward
someone using mind- and mood-altering substances (Brown, 2011). Brown (2011) found
the internal consistency for this measure to be α = .92. This measure was originally
adapted from three measures of mental illness stigma, the Social Distance Scale, the
Dangerousness Scale (Link, Cullen, Frank, & Wozniak, 1987), and the Affect Scale
(Penn et al., 1994). The AS-SU measures the level of stigma a participant has for an
addicted person by inquiring about factors such as his or her comfort with interacting
with someone with a substance use disorder, perception of his or her personality, and
types of emotions toward an addicted person. The author advised that in subsequent
research, the phrase “substance use disorder” should be substituted with the specific
substance of interest due to research indicating that stigma can vary based on substance

FACTORS THAT PREDICT NALOXONE ADMINISTRATION

21

(Brown, 2011). Because of this, “substance use disorder” was changed to “opioid use
disorder” for the purpose of this study.
Likert-scale regarding civil and legal concerns. Two items were measured
using a Likert-like scale. In the first item, participants were asked to rate their concern
regarding legal action in retaliation for using naloxone. In the second item, participants
were asked to rate the same level of concern; however, they were asked to identify their
level of concern with civil action.
Modified Attributions of Obesity Scale. The Attributions of Obesity Scale
(Foster et al., 2003) was developed to assess physicians’ attitudes toward obese patients.
This measure consists of multiple sections inquiring about physician characteristics and
viewpoints in working with obese patients. The sections of this measure examine
physicians’ characteristics (heights and weight, type of practice, income level of typical
patient) and case conceptualization questions regarding patients with the presenting
problem of obesity. The final two sections of this assessment ask the physician about his
or her attributions of obesity and characteristics he or she attributes to obese patients.
These final two sections were adapted for this study, to form the Attributions of
Addiction Scale (AOAS).
In the first adapted section, participants were asked to provide a Likert-rating of 1
(Strongly Disagree) to 5 (Strongly Disagree) to measure how much their beliefs are in
accordance with each statement. The wording of these items were changed from “obese
patients” to “addicted persons.” The following items were eliminated due to the inability
to be adapted from physician rating to layperson and/or from obesity to addiction: “I
make accommodations for obese patients by providing big thigh cuffs, large hospital
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gowns, and armless chairs,” “I am usually unsuccessful in helping obese patients lose
weight,” “I would spend more time working on weight management issues with patient if
my time was reimbursed appropriately,” “A 10% reduction in body weight is sufficient to
improve of control obesity-related health complications,” and “Physicians should be role
models by maintaining normal weight.”
The second adapted section asked the participant to rate their beliefs about
characteristics of obese patients on a 7-point Likert scale. The items consist of 15 pairs
of opposite adjectives (e.g., bad/good, compliant/noncompliant, weak-willed/strongwilled). The directions for this section inform the participant the adjectives are
commonly used to describe “obese patients.” The wording of these instructions was
adapted to state the adjectives are used to describe “addicted persons.”
Procedure
Prior to dissemination, IRB approval was obtained at Philadelphia College of
Osteopathic Medicine (PCOM). A document containing the information regarding the
study and raffle, the demographic questionnaire, the vignette, the TEQ, the AS-SU, the
Likert-items regarding civil and legal concern, and the Modified Attributions of Obesity
Scale (Attributions of Addiction) were created. The information were uploaded to
Research Electronic Data Capture (REDCap) with consideration for order effect of the
included measures. Undergraduate students were recruited via social media groups for
college students, where posts were created to inquire about their interest to participate in
this study. The inquiry included the REDCap link. When interested students clicked the
link, they saw a page that thanked them for their participation and a detailed description
of the study and what they were being asked to do. Participants were informed about the
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benefits of the study, which include assisting to further research concerning naloxone
administration for those who have overdosed, the personal experience of participating in
a research study, and being entered into a drawing for an Amazon gift card. They were
informed the potential risks of participating in the study, including costing 15 to 20
minutes of their time and potential discomfort from the questions and exposure to the
scenario. This disclosure concluded by again thanking them for their participation in the
study and by asking them to answer all questions to the best of their ability. The
conclusion of the disclosure also reminded participants that their participation in this
study remained completely anonymous, and that it was voluntary and could be exited at
any time. Upon completion of data collection via REDCap, the researcher analyzed the
data using SPSS.
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CHAPTER 4: RESULTS
A logistic regression was used to examine the relationship of the hypothesized
predictor variables on the dichotomous criterion variable of administering or not
administering naloxone in the vignette. A logistic regression of a binary response
variable (Y) on a continuous, normally distributed variable (X) with a sample size of 120
completed surveys achieves 80% power at a 0.05 significance level.
All information was collected via REDCap and entered into SPSS for analysis.
Descriptive statistics were used to assess the age of the participants, annual household
income, concern of legal and civil ramifications, and total scores on the TEQ, AS-SU and
AOAS. A Pearson correlation was used to assess the relationship between the decision to
administer naloxone and participant predictor variables including sex, age, race, whether
the participant had or knew someone with a substance abuse problem, whether the
participant was aware of anyone who ever needed to be given naloxone, whether he or
she was naloxone trained, whether those trained carried naloxone on a regular basis, area
of study, annual household income, concern over legal ramifications, concern over civil
ramifications, total TEQ score, total AS-SU score, and total AOAS score.
Participant responses were dichotomized into either administer or not administer
naloxone for the purposes of the logistic regression. The participants who chose any
other action (call 911, have someone else administer naloxone, etc.) were categorized
into the “not administer” group. The logistic regression was used to examine whether the
independent variables could be used to predict the criterion variable. The data were
entered in a nonspecific order, using the SPSS “enter” function, and did not use a stepwise data entry, as the variables were all thought to be of equal importance.
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Sample Demographics
A total of 129 participants met all inclusion criteria and completed the full survey
and, therefore, were included in the analysis for the present study. Of these participants,
32 (24.8%) were male and 97 (75.2%) were female. Participants’ ages ranged from 18 to
65 with an mean of 23.80 (SD = 7.33; see Table 1). Of the 129 participants, 115 (89.1%)
were Caucasian, 2 (1.6%) were African American, 5 (3.9%) were Hispanic, and 7 (5.5%)
described themselves as either Asian or Other. Area of study was included in the
demographic information collected. The sample consisted of 22 (17.1%) nursing/biology
students, 30 (23.3%) psychology/human studies students, 21 (16.3%)
business/management/mathematics students, 5 (3.9%) trade/technical school students,
and 35 (27.1%) “other” students. Sixteen (12.4%) participants chose not to disclose their
areas of study. Annual household income ranged from $6,000.00 to $600,000.00 with a
mean income of $80,269.61.
Only 117 (90%) respondents chose to provide information regarding their
experiences with naloxone. Of those who chose to provide this information (117), 62
(53.0%) reported either themselves, family members, or friends who have had problems
with substance abuse, 55 (47.0%) reported they, family members, or friends did not
experience problems with substance abuse, and 12 participants chose not to answer this
question. The same number of participants, 117 (90%), chose to disclose whether they
have had personal experience with needing naloxone. Of the 117 respondents, 98
(83.8%) said they, family members, or friends have not needed naloxone, whereas 19
(16.2%) reported either they, family members, or friends have been administered
naloxone. Finally, of the 117 participants who provided information regarding their
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experiences with naloxone, 101 (86.3%) participants reported that they have not been
trained in the proper administration of naloxone, and 16 (13.7%) reported they have had
the recommended training in proper administration. Of these 16 (13.7%) trained
participants, only 2 (1.8%) respondents reported they carry naloxone with them regularly.
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Sample Demographics
Variable

N (%) or M (SD)

Gender
Male
Female

32 (24.8%)
97 (75.2%)

Age (years)

23.80 (7.33)

Ethnicity
White
African American
Hispanic
Other

115 (89.1%)
2 (1.6%)
5 (3.9%)
7 (5.5%)

Area of Study
Nursing/ Biology
Psychology/Human Services
Business/Management/Mathematics
Trade/Technical
Other
Did Not Disclose

22 (17.1%)
30 (23.3%)
21 (16.3%)
5 (3.9%)
35 (27.1%)
16 (12.4%)

Annual Household Income

$80,269.61 (80,264.90)

Experienced Problems with Substance Abuse
Yes
No
Aware of the Purpose of Naloxone
Yes
No
Needed Naloxone
Yes
No
Been Trained in The Proper Administration
of Naloxone
Yes
No
If Yes, Carry it with You
Yes
No
N/A

62 (53.0%)
55 (47.0%)

77 (66.4%)
39 (33.6%)

19 (16.2%)
98 (83.8%)

16 (13.7%)
101 (86.3%)
2 (1.8%)
24 (21.4%)
86 (76.8%)
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Bivariate Correlations
To analyze a potential relationship between variables, bivariate correlations were
computed for the 11 predictor variables (sex, age, race, problems with substance abuse,
awareness of purpose of naloxone, history of needing naloxone, being naloxone trained,
carrying naloxone if trained, TEQ score, AS-SU score, and AOAS score) and the
dichotomized criterion variable (administering naloxone [Y/N]). These analyses assisted
in determining whether any of the predictor variables were not correlated with the
criterion variables and, therefore, needed to be excluded from the regression.
Additionally, this analysis served to find any instances of multicollinearity. Table 2
depicts significant associations that were identified between predictor and criterion
variables.
Significant associations were found between some of the predictors and the
criterion variable, administering naloxone: TEQ score (R = .203, p > 0.05), AS-SU score
(R = -.190, p > 0.05), and AOAS score (R = .208, p > 0.05). There were statistically
significant correlations between predictor variables, but these correlations were not
strong enough to signal multicollinearity; therefore, the logistic regression was run
without eliminating variables.
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Table 2
Bivariate Correlation Matrix of Predictors and Criterion Variable: Decision to
Administer Naloxone

Note: ** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)

Logistic Regression
Prior to the analysis, assumptions associated with regression including normality,
linearity, homoscedasticity, and multicollinearity were evaluated. The normality
assumption was evaluated using the Shapiro-Wilks test and histograms. A plot of
standardized residuals versus predicted values was used to determine homoscedasticity.
Multicollinearity was tested by examining bivariate correlations between all independent
variables. If any two variables were found to be highly correlated, a decision would have
been made regarding which one to drop from the regression model.
An exploratory analysis included the percentage of each response to provide
information about the proportion of participants who would (a) administer naloxone, (b)
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ask someone else to administer the naloxone, (c) call 911, (d) ensure another witness calls
911, or (d) not get involved.
A binomial logistic regression was performed to ascertain the predictive nature of
empathy, stigma toward substance users and personal attributions toward substance use
on the likelihood that participants would choose to administer naloxone in the event they
encountered someone experiencing an overdose. Linearity of the continuous variables
with respect to the logit of the criterion variable was assessed via the Box-Tidwell
procedure. The logistic regression model was statistically significant, χ2(3) = 13.595, p <
.004. The model explained 14.0% (Nagelkerke R2) of the variance in decision to
administer naloxone and correctly classified 61.7% of cases. The positive predictive
value was 73.2% and negative predictive value was 47.4%. Of the three predictor
variables, only one was statistically significant: TEQ score (as shown in Table 3).
Neither the AS-SU or the AOAS scores reached statistical significance (p = .26, p =
.052).

Table 3
Logistic Regression Predicting Decision to Administer Naloxone
B

SE

Wald

df

p

Odds
Ratio

TEQ
Score

.11

.05

4.98

1

.03

1.12

AS-SU
Score

-.02

.02

1.25

1

.26

.98

AOAS
Score

.13

.07

3.77

1

.05

1.14
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CHAPTER 5: DISCUSSION
Interpretation and Implications
Hypothesis 1. It was hypothesized that participants with higher levels of
empathy would be significantly more likely to administer naloxone. The results of both
the bivariate correlation and the logistic regression demonstrated a relationship between
the level of empathy and the decision to administer naloxone. The achieved statistical
significance demonstrated a high level of empathy as a predictor of the decision to
administer naloxone in the event a person encounters someone experiencing an opioid
overdose. These results provide support for the first hypothesis.
Hypothesis 2. It was hypothesized that participants with lower levels of stigma
toward opioid users would be significantly more likely to administer naloxone. The
results of the bivariate correlation demonstrated an inverse relationship between the level
of stigma and the decision to administer naloxone. This would support the second
hypothesis. Upon further analysis, the logistic regression did not reach statistical
significance. Due to the results of the logistic regression, the second hypothesis was not
supported, and a low level of stigma was not identified as a predictor of the decision to
administer naloxone.
Hypothesis 3. It was hypothesized that participants with lower levels of concern
regarding legal/civil ramifications would be significantly more likely to administer
naloxone. During preliminary analyses, the concern over both legal and civil
ramifications was not found to be significantly correlated with the decision to administer
naloxone. Therefore, this variable was not included in the logistic regression. Because
of this, this hypothesis was not supported, and concern over legal/civil ramifications was
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not determined to relate to the decision to administer naloxone in the event of an
overdose.
Hypothesis 4. It was hypothesized that participants with significantly lower
degrees of negative attribution toward those who use opioids would be more likely to
administer naloxone. The bivariate correlation demonstrated a relationship between the
level of personal attribution toward substance use and the decision to administer
naloxone. The logistic regression demonstrated this relationship did not meet statistical
significance (p = .052). For this reason, hypothesis 4 was not supported, and personal
attribution level was not considered to be a predictor of the decision to administer
naloxone. It is possible that with a higher power, this relationship would have yielded
statistical significance and should be considered in further research.
Interpretation of the results of this study indicates that of the four hypotheses, the
variable that had the most significant impact on the decision to administer naloxone to
someone overdosing on opioids was level of empathy, with people who have higher
empathy being more likely to administer it. It is important to note the measure used
considered the general construct of empathy, not empathy toward those who use
substances specifically.
Although not statistically significant as predictors, both levels of stigma and
levels of personal attribution were correlated with the decision to administer naloxone.
This indicates that, although not predictive, low levels of stigma and personal attribution
for substance abuse appear to be linked to the decision to administer naloxone.
Finally, the concerns of legal and civil ramifications were not correlated with the
decision to administer naloxone. This means that there was no significant relationship
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found between the level of concern of being charged with a crime or lawsuit and the
ultimate decision of administering naloxone to someone experiencing an overdose.
The implications of this study are vast. The results of this study can be utilized to
inform multiple facets of the efforts to use naloxone to save lives in the event of opioid
overdoses. This study may provide useful information regarding the degree to which
individuals are willing to administer naloxone and factors that may influence this
decision. Knowledge about the factors that increase an individual’s likelihood of
administering naloxone can be useful to many groups of people, such as policymakers,
educators, and family counselors. The information gathered in this study can be used to
adapt programs to capitalize on these factors. Since results indicate that level of empathy
predicts the decision to utilize naloxone, training efforts should include material that is
used to foster empathy. Furthermore, because results support an inverse relationship
between stigma and the decision to administer naloxone, those who work in the
prevention field can direct their efforts toward fighting stigma. The same can be said for
the levels of personal attribution toward those with substance use problems: Training
efforts can provide information that lowers the level of personal attribution and
capitalizes on disseminating the disease concept of addiction to decrease beliefs
concerning the overdosed persons’ choice to use drugs. This same information can be
utilized to empirically justify funding toward the aforementioned prevention efforts.
In addition to providing insight into the administration of naloxone, the results of
this study can inform the strategies of future public outreach programs for substance use
and naloxone administration. The factors that are associated with the decision to
administer naloxone can be utilized to direct the efforts of those working in prevention.
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The results of this study demonstrate that high empathy is correlated with the decision to
administer naloxone; therefore, outreach efforts can be targeted toward the public’s
empathy.
Results measuring the degree of the endorsement of the disease concept cannot
definitively identify whether the disease concept is permeating into the general public.
The results demonstrate the sample in this study have some levels of personal attribution,
indicating they may endorse a moralistic view of substance use; therefore, the results are
indicative of the need for further education regarding the disease concept of addiction.
Limitations
The primary limitation of this study is the use of a convenience sample. As such,
the results of this study may only generalize to college students. The decision to use a
convenience sample was made with the acknowledgement of trading potential
randomization and generalizability for a sample with similar ages, education levels, and
exposure to contemporary teachings about substance use disorders. Although
socioeconomic data were collected, it was within a sample of college students and results
may not generalize to low-education families. In addition, other possible variables of
interest were represented due to being missing from the demographic information. For
example, one variable that was not collected was previous legal history. It is conceivable
that those with legal histories may have more concern about legal ramifications if they
have some sort of probation or parole indicating they are not to have interactions with the
authorities. It is also conceivable this higher level of concern may impact their decisions
more than those who have no legal histories.
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Additionally, the use of a vignette may impact the ecological validity of this
study. Because the vignette indicates the participant has had the training to carry
naloxone, the reported likelihood of administration may be inflated. This was mitigated
by adding an item asking the participant to indicate how closely he or she believes his or
her choice of action matches how he or she would respond in real life. During the
primary analyses, a correlation was not found between confidence ratings and decisions
to administer naloxone (See Table 1). This indicates that people’s actions may differ in
real-life scenarios; however, it appears that participants took this into consideration due
to the neutral nature of the mean of the responses. This may be the result of high, yet not
perfect, confidence in their chosen next courses of action. Similarly, the use of selfreport measures may impact the validity of participant responses due to the potential
presence of the Hawthorne effect. In future versions of this study, it may be helpful to
include some measure of social desirability, such as the Marlowe-Crowne Social
Desirability Scale, order to mitigate this limitation.
The use of social media to collect data can be a limitation in interpreting these
results. Due to the nature of social media, inferences cannot be made about specific
geographic or cultural regions. Data collection via social media also requires the
participants to answer honestly to the questions concerning the inclusion criterion and
that each participant only took the survey one time. A limitation identified after data
collection included that the annual household income was not specified to being USD and
could have been entered in another currency rate, which may impact the accuracy of the
socioeconomic statuses represented in the sample.
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Another limitation of this study is the use of an adapted measure to quantify the
participant’s level of personal attribution toward those using opioids. The adapted
version of the Attributions of Obesity Scale has no established validity or reliability.
Although this measure has not been validated to measure attitudes toward the substance
using population, it is believed that items measure the same concepts with relation to a
compulsive behavior. After data collection, it was decided to not use the full adapted
measure because some items did not fully measure the desired construct. Instead, only
four questions were used in the analysis: 1. Addiction is a chronic disease of the brain, 2.
Most addicted people could stop using drugs if they were motivated to do so, 5, Medical
care for addicted patients without any other medication conditions should be covered by
healthcare, and 11. It is difficult to feel empathy for an addicted person. These items
were chosen as it was deemed their answers would measure the level of personal
attribution that would equate to endorsing either the disease concept or moral model.
Due to the lack of psychometrics on this measure, it is plausible that the biases of the
researchers impacted the chosen items.
Additionally, there are only two items that measured the participants’ concern
regarding the potential for legal/civil ramifications. The lack of items measuring this
concept may mean that the construct was not accurately measured as a factor in the
participants’ decision whether to administer naloxone in the vignette.
Furthermore, the choice provided could have dichotomized the participants’
options to either help or not help the encountered individual. The decision was made to
provide additional responses to learn more about the various degrees of help a participant
would choose to provide.
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The formatting of this survey can be considered a limitation. The present study
used an adapted version of the Attributions of Obesity Scale (Foster et al., 2003). The
final section of this measure included a semantic differential scale that did not include
anchors. This format did not seemlessly transfer into the REDcap software, which could
have potentially caused confusion for the participants. Similarly, the entire survey
consisted of 69 items. Upon analyzing the data, it was found that 233 participants started
the survey, yet only 128 surveys were able to be analyzed. The remainder of the surveys
were not able to be analyzed due to not being completed. Future adapatations of this
study may benefit from condensing items to have a higher completion rate of responses.
Future Directions
Future variations of this study should be completed with varying populations.
Assessing the likelihood of naloxone administration is important among non-student
adults, first-responders, newly trained individuals, college staff, and beyond. Each group
possesses unique qualities that may impact their decisions to utilize naloxone should they
encounter an overdosed person. Future research with various populations would allow
for further development in the efforts to expand the carrying and utilization of naloxone.
These results can be used to assess and develop various training methods for
opioid overdose recognition and naloxone administration. Future studies can take the
results of the present study and assess training efforts and ensure they are capitalizing on
the characteristics that will contribute to trainees’ decisions to use naloxone. It would
also be beneficial to assess the factors that contribute to an individual’s decision to
become trained in naloxone.
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Considering results indicate empathy as a predictor of the decision to administer
naloxone, it would be imperative for future research to examine how to build empathy for
those afflicted with substance use disorders and implement those results into training
strategies. The knowledge gained in this study could change the modalities of naloxone
training to foster empathy and increase the likelihood that the participants of trainings
will carry and use naloxone should they encounter someone who has overdosed.
The knowledge that empathy is an indicator of someone choosing to administer
naloxone can be a helpful tool in clinical situations. This information can be used to
increase empathy in family members of those seeking treatment for OUD. If family
members have empathy for a newly discharged patient, they have the potential to accept
the recommendation of keeping naloxone in their homes to use in the event of a relapse.
The results of this study can be used to inform future policy. Identifying factors
that increase the likelihood of individuals carrying and utilizing naloxone may help
policymakers more effectively develop strategies to combat deaths caused by opioid
overdose. Informed and effective policies can change public perceptions regarding
opioid addiction. Reducing public stigma can help addiction to be viewed the same as
other chronic relapsing conditions, such as diabetes and asthma, and pave the way for
naloxone to be as visible and accessible as a defibrillator. Greater accessibility to
naloxone will greatly increase public safety and reduction of opioid deaths.
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APPENDIX A
Demographic Questionnaire

1. Biological Sex: Male____ Female____
2. Are you 18 years of age or older? Yes____ No____
3. Age (in years):
4. Race/Ethnicity:
a.
b.
c.
d.
e.
f.
g.

White
Black or African American
Hispanic, Spanish, or Latino
American Indian or Alaskan Native
Asian
Native Hawaiian or Pacific Islander
Other

5. Are you currently enrolled in an undergraduate or trade school program? Yes ___
No___
6. Area of Study/College Major:________________
7. Household income past year (if you live with your parent/guardian when school is
not in session, include their income):_________
8. Have you, a family member, or friend experienced problems with substance use
or misuse? Yes____ No____
9. Are you aware of the purpose of naloxone (i.e., Narcan/Evzio)? Yes____
No____
10. Have you, a family member, or friend ever needed to be given naxolone
(Narcan/Evzio)? Yes____ No____
11. Are you currently trained in the proper administration of naloxone (i.e.,
Narcan/Evzio)? Yes____ No____
12. If yes, do you carry it with you regularly Yes____ No____ Not Applicable _____
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APPENDIX B
Vignette
Please read the following vignette and respond to the corresponding item to
indicate your next course of action.
You have been trained on the proper administration of naloxone, a nasal spray
designed to reverse the effects of an opioid overdose. You also learned that the
medication has no adverse effects even if used with someone who is not experiencing an
overdose. You have 1 dose with you in your backpack. As you are traveling to class,
you decide to stop in a convenience store to buy a cup of coffee and use the restroom.
When you enter the convenience store, there are a few other customers in addition to the
clerk. Upon entering the restroom, you notice a person sitting on the floor in the corner of
the room. The person is slumped over on the floor and is breathing so slowly that it is
almost hard to tell if they are breathing at all. They do not respond when you ask if they
are feeling ok, and you see their lips are beginning to turn a shade of blue. You then see
marks on their arm and immediately recognize this as an opioid overdose.
Please indicate your next course of action:
(1) administer naloxone by spraying a partial dose in each nostril
(2) ask another customer to administer the naloxone
(3) call 911 yourself without administering naloxone
(4) ensure another witness calls 911
(5) not get involved

How confident are you, on a scale of 1-5 (1 being not confident and 5 being completely
confident) that you would definitely follow this course of action in real life?
Not
Completely
Confident
Confident
1

2

3

4

5
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APPENDIX C
Concern Over Legal/Civil Ramifications
Please indicate, on a scale of 1-5 (1 being did not influence and 5 being
completely influenced) the degree to which your concerns about potential legal
ramifications (being charged with a crime) may have influenced the course of action you
took in the previous scenario.
Did Not
Influence
1

Completely
Influenced
2

3

4

5

Please indicate on a scale of 1-5, (1 being did not influence and 5 being
completely influenced) the degree to which your concerns about potential civil
ramifications (being subject to a lawsuit) may have influenced the course of action you
took in the previous scenario.
Did Not
Influence
1

Completely
Influenced
2

3

4

5
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APPENDIX D
Toronto Empathy Questionnaire
Below is a list of statements. Please read each statement carefully and rate how
frequently you feel or act in the manner described. Circle your answer on the response
form. There are no right or wrong answers or trick questions. Please answer each
question as honestly as you can.
Never Rarely Sometimes Often Always
1.

When someone else is feeling excited,
I tend to get excited too

0

1

2

3

4

2.

Other people's misfortunes do not
disturb me a great deal
It upsets me to see someone being
treated disrespectfully
I remain unaffected when someone
close to me is happy
I enjoy making other people feel better
I have tender, concerned feelings for
people less fortunate than me
When a friend starts to talk about
his\her problems, I try to steer the
conversation towards
something else
I can tell when others are sad even
when they do not say anything
I find that I am "in tune" with other
people's moods
I do not feel sympathy for people who
cause their own serious illnesses
I become irritated when someone cries
I am not really interested in how other
people feel
I get a strong urge to help when I see
someone who is upset

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

3.
4.
5.
6.
7.

8.
9.
10.
11.
12.
13.

14. When I see someone being treated
unfairly, I do not feel very much pity
for them
15. I find it silly for people to cry out of
happiness
16. When I see someone being taken
advantage of, I feel kind of protective
towards him\her
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APPENDIX E
Affect Scale for Substance Users (AS-SU)
Indicate how you would feel if you interacted with someone with an opioid use
disorder?
Pessimistic
Tranquil
Supportive
Fearful
Empathic
Disgusted
Apprehensive
Irritable
Relaxed
Calm

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5

6
6
6
6
6
6
6
6
6
6

7
7
7
7
7
7
7
7
7
7

Optimistic
Anxious
Resentful
Confident
Angry
Sympathetic
Comfortable
Patient
Tense
Nervous
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APPENDIX F:
Attributions of Addiction Scale
Using the following scale, please indicate the degree to which you agree or
disagree with the statements below.
1 – Strongly Disagree

2 – Disagree

3 – Neutral

4- Agree

5 – Strongly Agree

___ Addiction is a chronic disease associated with differences in the brain.
___ Most addicted people could stop using drugs if they were motivated to do so.
___ I have negative reactions toward addicted people based on their appearance.
___ I am obligated to educate addicted people on the health risks of using drugs.
___ Medical care for addicted patients without any other medical conditions
should be
covered by health care.
___ For most people addicted to drugs, long-term abstinence is impossible.
___ Addicted persons are well aware of the health risks of drug use.
___ I often feel uncomfortable when interacting with an addicted person.
___ Most drug addicted persons will not become abstinent.
___ It does not hurt to apply “scare tactics” to encourage addicted persons to
convince them to stop using drugs.
___ It is difficult to feel empathy for an addicted person.
___ I feel like I have a good understanding of how someone becomes addicted.
Listed below are adjective sometimes used to describe addicted people.
Please indicate your beliefs about addicted people.
Successful
Weak-willed
Handsome
Graceful
Dirty
Pleasant
Dishonest
Warm

__ : __ : __ : __ : __ : __ : __
Unsuccessful
__ : __ : __ : __ : __ : __ : __ Strong-Willed
__ : __ : __ : __ : __ : __ : __
Ugly
__ : __ : __ : __ : __ : __ : __
Awkward
__ : __ : __ : __ : __ : __ : __
Clean
__ : __ : __ : __ : __ : __ : __
Unpleasant
__ : __ : __ : __ : __ : __ : __
Honest
__ : __ : __ : __ : __ : __ : __
Cold

Bad
__ : __ : __ : __ : __ : __ : __
Good
Sloppy
__ : __ : __ : __ : __ : __ : __
Neat
Compliant
__ : __ : __ : __ : __ : __ : __ Noncompliant
Hard to talk to
__ : __ : __ : __ : __ : __ : __ Easy to talk to
Attractive
__ : __ : __ : __ : __ : __ : __
Unattractive
Lazy
__ : __ : __ : __ : __ : __ : __
Industrious
Likeable
__ : __ : __ : __ : __ : __ : __ Not Likeable

